Developer docs
API playgroundTry for free, no card

Search company profiles

Hospitech Respiration

Full company profile

uuid000bbop

Namestring
Hospitech Respiration
Legal namestring
Hospitech Respiration Ltd.
Websiteurl
hospitech.co.il
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Hospitech Respiration Ltd is an Israeli medical device company founded in 2006, headquartered in Kfar Saba with an additional office in Petah Tikva. The company develops and commercializes the AnapnoGuard platform, an integrated airway management solution for mechanically ventilated patients in hospital and ICU settings. Its core technology combines continuous CO2 monitoring in the subglottic space with closed-loop automated cuff pressure control, enabling real-time adjustment of endotracheal tube cuff pressure based on physiological leak detection. The system pairs the reusable AG100s Control Unit (capital equipment) with a disposable triple-lumen AG Endotracheal Tube featuring a thin-walled polyurethane cuff, allowing simultaneous subglottic rinsing and secretion evacuation to reduce ventilator-associated pneumonia and tracheal tissue injuries. Manual alternatives (AG Cuffill manometer and AG MASS suction device) serve settings where the automated unit is unavailable.

The company's revenue model is based on hardware sales, combining capital equipment placement with recurring disposable tube consumption tied to ventilated patient volume. Hospitech commercializes through a hybrid go-to-market approach: direct sales to hospital procurement and clinical departments supplemented by distribution partnerships, most notably the March 2024 divestiture of the AG Cuffill product line to Medline Industries for global channel distribution. The company holds US FDA 510(k), European CE Mark, and China CFDA regulatory approvals, and reports commercial presence in over 35 countries across Europe, the Americas, Asia-Pacific, and Oceania. Multiple peer-reviewed clinical studies and randomized controlled trials support the platform's safety and efficacy claims, serving as a primary marketing and differentiation lever in clinical procurement decisions.

Short descriptiontext

Hospitech Respiration is an Israeli medical device company that develops the AnapnoGuard platform, providing automated endotracheal tube cuff pressure control and subglottic secretion evacuation for mechanically ventilated patients in hospitals and ICUs across 35+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKfar Saba, Israel
HQ citystring
Kfar Saba
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
airway management devices, mechanical ventilation products, endotracheal tubes, cuff pressure control, subglottic secretion evacuation
Industry3 codes
PRIMARYHLAHAGAC
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAHADAK
Suction, Irrigation & Fluid Management Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAGAI
Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Airway Management Medical Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1AnapnoGuard AG100s Control Unit (Capital Equipment)
TypeHardware Sales
Description

The AG100s Control Unit is a reusable hardware device sold as capital equipment to hospitals and ICUs. The device provides automated cuff pressure control and subglottic secretion management for mechanically ventilated patients.

hospitech.co.il
2AG Endotracheal Tube (Disposables)
TypeHardware Sales
Description

The AnapnoGuard Endotracheal Tube is a single-use disposable device. The AG MASS is also a single-use device for manual secretion management. These create recurring disposable revenue tied to the volume of mechanically ventilated patients.

hospitech.co.il
3AG Cuffill Manual Digital Manometer
TypeHardware Sales
Description

The AG Cuffill is a manual digital manometer sold as a single-use or reusable device for easy monitoring and adjustment of ET Tube cuff pressure. This product was licensed/acquired by Medline for broader distribution.

hospitech.co.il
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1AnapnoGuard
Description

Automated ET Tube cuff pressure control and subglottic secretion evacuation solution for mechanically ventilated patients, consisting of the AG100s Control Unit and AG Endotracheal Tube.

hospitech.co.il
+2 more records
Core offering1 text field

Hospitech Respiration develops and commercializes the AnapnoGuard platform for airway management in mechanically ventilated patients. The platform combines the reusable AG100s Control Unit, which uses continuous CO2 monitoring in the subglottic space to automatically adjust endotracheal tube cuff pressure, with a triple-lumen AG Endotracheal Tube that simultaneously rinses and evacuates subglottic secretions. Disposable accessories include the AG MASS manual suction device and the AG Cuffill digital manometer for use when the automated control unit is not available.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • In the De Pascale et al. randomized controlled study (2017), use of the AnapnoGuard AG100 system was found to be safe and effective for automated cuff pressure control and subglottic secretion drainage in critically ill intubated patients.
Product overview1 text field

Hospitech Respiration provides the AnapnoGuard platform, an innovative therapeutic solution for mechanically ventilated patients. The platform consists of automated and disposable devices: the AG100s Control Unit (the core automated system) works in conjunction with the AG Endotracheal Tube to provide automated cuff pressure control and effective subglottic secretion evacuation. When the automated system is unavailable, clinicians can use manual alternatives including the AG Cuffill (manual manometer) and AG MASS (single-use suction device).

Product and service4 records
1AnapnoGuard AG100s Control Unit
CategoryAirway management capital equipment
Description

Integrated, multi-purpose airway management system providing automated endotracheal tube cuff pressure control through closed-loop CO2 monitoring and effective evacuation of subglottic secretions via simultaneous rinsing and suction; sold as capital equipment to hospitals and intensive care units managing mechanically ventilated patients.

2AG Endotracheal Tube
CategoryDisposable airway management devices
Description

Single-use disposable advanced endotracheal tube with three unique lumens (two for suction, one for venting/rinsing) and a thin-walled polyurethane cuff with advanced sealing properties, designed to prevent complications from prolonged mechanical ventilation including infections and tracheal injury in critically ill intubated patients.

3AG Cuffill
CategoryDisposable and reusable airway accessories
Description

Manual digital manometer for easy monitoring and adjustment of endotracheal tube cuff pressure when the automated AG100s Control Unit is not available; distributed via Medline Industries following its 2024 acquisition of the AG Cuffill product line from Hospitech.

4AG MASS
CategoryDisposable airway management accessories
Description

Single-use device for manual rinsing and suction of subglottic secretions used in clinical settings where the automated AnapnoGuard AG100s Control Unit is not available, supporting subglottic secretion management to help prevent ventilator-associated pneumonia.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Medline Industries, LP
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-03-20
Description

In March 2024, Medline Industries LP acquired the AG Cuffill product line from Hospitech Respiration Ltd. The acquisition reflects a strategic partnership where Hospitech leverages Medline's extensive global distribution network to commercialize its airway management products. Medline committed to retaining AG Cuffill as an integral part of its market-leading airway management portfolio, with Hospitech CEO Yoav Venkert expressing commitment to further cooperation with Medline to commercialize more of its product portfolio.

hospitech.co.il
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Teleflex is a major airway management incumbent with a broad portfolio of endotracheal tubes (including subglottic suction tubes like the Iso-Gard) and is one of the dominant competitors Hospitech faces in ICU ET tube purchasing decisions globally.

2Smiths Medical
TypeBroad incumbent
Description

Smiths Medical (ICU Medical) markets Portex endotracheal tubes and other airway management devices into hospitals, providing a multi-product incumbent alternative to the AnapnoGuard platform in ICU airway management.

3Medline Industries
TypeOthers
Description

Medline Industries is Hospitech's channel partner and acquired the AG Cuffill product line; Medline is also a major distributor/manufacturer of competing airway management products and represents both an enabler and a potential competitor in the same hospital accounts.

4VBM Medizintechnik
TypeDirect peer
Description

VBM Medizintechnik manufactures cuff pressure gauges/manometers (e.g., Cuff Pressure Gauge) and airway management accessories, directly overlapping with Hospitech's AG Cuffill manual manometer product concept in the same clinical use case.

TypeBroad incumbent
Description

Ambu is a publicly listed specialist in single-use devices including airway management and anesthesia products, competing with Hospitech's disposable ET tube offering in hospital and ICU channels globally.

TypeDirect peer
Description

Intersurgical is a European-based respiratory care and airway management device manufacturer offering endotracheal tubes, suction devices, and related consumables, directly competing with Hospitech in the ICU ET tube category across similar geographies.

TypeBroad incumbent
Description

Medtronic's Respiratory Interventions business (inheriting Covidien's portfolio) offers Shiley endotracheal tubes and related airway management products sold directly into ICUs, representing a large-scale incumbent competing for the same procurement budgets as Hospitech.

8Cook Medical
TypeBroad incumbent
Description

Cook Medical manufactures a range of airway management and critical care devices sold into hospital and ICU channels, representing an additional broad incumbent in the same hospital procurement environment Hospitech targets.

9TRACOE Medical
TypeRegional player
Description

TRACOE Medical specializes in tracheostomy and airway management devices, addressing similar patient populations (intubated and tracheostomized ICU patients) and competing in selected European markets where Hospitech also sells.

TypeEmerging player
Description

Venner Medical has developed the PneuX endotracheal tube with subglottic secretion drainage and continuous cuff pressure monitoring, a direct technical and clinical competitor to AnapnoGuard's combined cuff pressure + secretion evacuation approach.

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hospitech Respiration

Airway Management Medical Deviceshospitech.co.il

Hospitech Respiration is an Israeli medical device company that develops the AnapnoGuard platform, providing automated endotracheal tube cuff pressure control and subglottic secretion evacuation for mechanically ventilated patients in hospitals and ICUs across 35+ countries.

What Hospitech Respiration does

Hospitech Respiration Ltd is an Israeli medical device company founded in 2006, headquartered in Kfar Saba with an additional office in Petah Tikva. The company develops and commercializes the AnapnoGuard platform, an integrated airway management solution for mechanically ventilated patients in hospital and ICU settings. Its core technology combines continuous CO2 monitoring in the subglottic space with closed-loop automated cuff pressure control, enabling real-time adjustment of endotracheal tube cuff pressure based on physiological leak detection. The system pairs the reusable AG100s Control Unit (capital equipment) with a disposable triple-lumen AG Endotracheal Tube featuring a thin-walled polyurethane cuff, allowing simultaneous subglottic rinsing and secretion evacuation to reduce ventilator-associated pneumonia and tracheal tissue injuries. Manual alternatives (AG Cuffill manometer and AG MASS suction device) serve settings where the automated unit is unavailable.

The company's revenue model is based on hardware sales, combining capital equipment placement with recurring disposable tube consumption tied to ventilated patient volume. Hospitech commercializes through a hybrid go-to-market approach: direct sales to hospital procurement and clinical departments supplemented by distribution partnerships, most notably the March 2024 divestiture of the AG Cuffill product line to Medline Industries for global channel distribution. The company holds US FDA 510(k), European CE Mark, and China CFDA regulatory approvals, and reports commercial presence in over 35 countries across Europe, the Americas, Asia-Pacific, and Oceania. Multiple peer-reviewed clinical studies and randomized controlled trials support the platform's safety and efficacy claims, serving as a primary marketing and differentiation lever in clinical procurement decisions.

Hospitech Respiration firmographics

Firmographics
Name
Hospitech Respiration
Legal name
Hospitech Respiration Ltd.
Website
https://hospitech.co.il
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Hospitech Respiration is an Israeli medical device company that develops the AnapnoGuard platform, providing automated endotracheal tube cuff pressure control and subglottic secretion evacuation for mechanically ventilated patients in hospitals and ICUs across 35+ countries.
Ownership category
akta.pro rank

Hospitech Respiration industry classification

Industry
Product category
Airway Management Medical Devices
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHAGAC
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAHADAK
Suction, Irrigation & Fluid Management Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAGAI
Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

  • Airway management devices
  • Mechanical ventilation products
  • Endotracheal tubes
  • Cuff pressure control
  • Subglottic secretion evacuation

Where Hospitech Respiration is headquartered

Location

Headquarters

HQ city
Kfar Saba
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

Hospitech Respiration business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. AnapnoGuard AG100s Control Unit (Capital Equipment): The AG100s Control Unit is a reusable hardware device sold as capital equipment to hospitals and ICUs. The device provides automated cuff pressure control and subglottic secretion management for mechanically ventilated patients.
  2. AG Endotracheal Tube (Disposables): The AnapnoGuard Endotracheal Tube is a single-use disposable device. The AG MASS is also a single-use device for manual secretion management. These create recurring disposable revenue tied to the volume of mechanically ventilated patients.
  3. AG Cuffill Manual Digital Manometer: The AG Cuffill is a manual digital manometer sold as a single-use or reusable device for easy monitoring and adjustment of ET Tube cuff pressure. This product was licensed/acquired by Medline for broader distribution.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Hospitech Respiration product offering

Product offering

Core offering

Hospitech Respiration develops and commercializes the AnapnoGuard platform for airway management in mechanically ventilated patients. The platform combines the reusable AG100s Control Unit, which uses continuous CO2 monitoring in the subglottic space to automatically adjust endotracheal tube cuff pressure, with a triple-lumen AG Endotracheal Tube that simultaneously rinses and evacuates subglottic secretions. Disposable accessories include the AG MASS manual suction device and the AG Cuffill digital manometer for use when the automated control unit is not available.

Product overview

Hospitech Respiration provides the AnapnoGuard platform, an innovative therapeutic solution for mechanically ventilated patients. The platform consists of automated and disposable devices: the AG100s Control Unit (the core automated system) works in conjunction with the AG Endotracheal Tube to provide automated cuff pressure control and effective subglottic secretion evacuation. When the automated system is unavailable, clinicians can use manual alternatives including the AG Cuffill (manual manometer) and AG MASS (single-use suction device).

Differentiator

Problem solved

Functional benefit

Brands

  • AnapnoGuard: Automated ET Tube cuff pressure control and subglottic secretion evacuation solution for mechanically ventilated patients, consisting of the AG100s Control Unit and AG Endotracheal Tube.
  • AG100s
  • AG Endotracheal Tube

Products and services

  • AnapnoGuard AG100s Control Unit Integrated, multi-purpose airway management system providing automated endotracheal tube cuff pressure control through closed-loop CO2 monitoring and effective evacuation of subglottic secretions via simultaneous rinsing and suction; sold as capital equipment to hospitals and intensive care units managing mechanically ventilated patients.
  • AG Endotracheal Tube Single-use disposable advanced endotracheal tube with three unique lumens (two for suction, one for venting/rinsing) and a thin-walled polyurethane cuff with advanced sealing properties, designed to prevent complications from prolonged mechanical ventilation including infections and tracheal injury in critically ill intubated patients.
  • AG Cuffill Manual digital manometer for easy monitoring and adjustment of endotracheal tube cuff pressure when the automated AG100s Control Unit is not available; distributed via Medline Industries following its 2024 acquisition of the AG Cuffill product line from Hospitech.
  • AG MASS Single-use device for manual rinsing and suction of subglottic secretions used in clinical settings where the automated AnapnoGuard AG100s Control Unit is not available, supporting subglottic secretion management to help prevent ventilator-associated pneumonia.

Quantifiable outcome

  • In the De Pascale et al. randomized controlled study (2017), use of the AnapnoGuard AG100 system was found to be safe and effective for automated cuff pressure control and subglottic secretion drainage in critically ill intubated patients.

Companies that use Hospitech Respiration

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Hospitech Respiration technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Hospitech Respiration partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Medline Industries, LPcoreChannel Partner/ Reseller/ Distributor · 20 March 2024In March 2024, Medline Industries LP acquired the AG Cuffill product line from Hospitech Respiration Ltd. The acquisition reflects a strategic partnership where Hospitech leverages Medline's extensive global distribution network to commercialize its airway management products. Medline committed to retaining AG Cuffill as an integral part of its market-leading airway management portfolio, with Hospitech CEO Yoav Venkert expressing commitment to further cooperation with Medline to commercialize more of its product portfolio.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Hospitech Respiration competitors and assessment

Company assessment

Broad incumbents

  • Teleflex: Teleflex is a major airway management incumbent with a broad portfolio of endotracheal tubes (including subglottic suction tubes like the Iso-Gard) and is one of the dominant competitors Hospitech faces in ICU ET tube purchasing decisions globally.
  • Smiths Medical: Smiths Medical (ICU Medical) markets Portex endotracheal tubes and other airway management devices into hospitals, providing a multi-product incumbent alternative to the AnapnoGuard platform in ICU airway management.
  • Ambu: Ambu is a publicly listed specialist in single-use devices including airway management and anesthesia products, competing with Hospitech's disposable ET tube offering in hospital and ICU channels globally.
  • Medtronic (Covidien): Medtronic's Respiratory Interventions business (inheriting Covidien's portfolio) offers Shiley endotracheal tubes and related airway management products sold directly into ICUs, representing a large-scale incumbent competing for the same procurement budgets as Hospitech.
  • Cook Medical: Cook Medical manufactures a range of airway management and critical care devices sold into hospital and ICU channels, representing an additional broad incumbent in the same hospital procurement environment Hospitech targets.

Others

  • Medline Industries: Medline Industries is Hospitech's channel partner and acquired the AG Cuffill product line; Medline is also a major distributor/manufacturer of competing airway management products and represents both an enabler and a potential competitor in the same hospital accounts.

Direct peers

  • VBM Medizintechnik: VBM Medizintechnik manufactures cuff pressure gauges/manometers (e.g., Cuff Pressure Gauge) and airway management accessories, directly overlapping with Hospitech's AG Cuffill manual manometer product concept in the same clinical use case.
  • Intersurgical: Intersurgical is a European-based respiratory care and airway management device manufacturer offering endotracheal tubes, suction devices, and related consumables, directly competing with Hospitech in the ICU ET tube category across similar geographies.

Regional players

  • TRACOE Medical: TRACOE Medical specializes in tracheostomy and airway management devices, addressing similar patient populations (intubated and tracheostomized ICU patients) and competing in selected European markets where Hospitech also sells.

Emerging players

  • Venner Medical (PneuX): Venner Medical has developed the PneuX endotracheal tube with subglottic secretion drainage and continuous cuff pressure monitoring, a direct technical and clinical competitor to AnapnoGuard's combined cuff pressure + secretion evacuation approach.

Market position

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Hospitech Respiration social profiles

Digital presence

Hospitech Respiration compliance and trust

Trust signal

Compliance3 records

Hospitech Respiration financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hospitech Respiration leadership team

Management profile

Number of profiles

Profiles4 records

Hospitech Respiration funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hospitech Respiration M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospitech Respiration

What does Hospitech Respiration do?

Hospitech Respiration develops and commercializes the AnapnoGuard platform for airway management in mechanically ventilated patients. The platform combines the reusable AG100s Control Unit, which uses continuous CO2 monitoring in the subglottic space to automatically adjust endotracheal tube cuff pressure, with a triple-lumen AG Endotracheal Tube that simultaneously rinses and evacuates subglottic secretions. Disposable accessories include the AG MASS manual suction device and the AG Cuffill digital manometer for use when the automated control unit is not available.

Is Hospitech Respiration a public or private company?

Hospitech Respiration is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Hospitech Respiration founded?

Hospitech Respiration was founded in 2006. It employs 11 to 50 people.

Where is Hospitech Respiration based?

Hospitech Respiration is headquartered in Kfar Saba, Israel, in the Middle East region.

How does Hospitech Respiration make money?

Three revenue lines are on record. AnapnoGuard AG100s Control Unit (Capital Equipment) is the primary driver. The others are AG Endotracheal Tube (Disposables) and AG Cuffill Manual Digital Manometer.

Who are Hospitech Respiration's main competitors?

Broad incumbents on record are Teleflex, Smiths Medical, Ambu, Medtronic (Covidien) and Cook Medical. Medline Industries is listed as an others. Direct peers are VBM Medizintechnik and Intersurgical. TRACOE Medical is listed as a regional player. Venner Medical (PneuX) is listed as an emerging player.

Does Hospitech Respiration have an API?

No public API is recorded for Hospitech Respiration.

What industry is Hospitech Respiration in?

Hospitech Respiration's product category is Airway Management Medical Devices. Its primary akta.pro industry code is HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home), with a secondary code of HLAHADAK, Suction, Irrigation & Fluid Management Systems. Its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireMedline Expands Respiratory Care PortfolioMedline and Hospitech Respiration Ltd. announced a distribution agreement effective October 2, 2020, making Medline the exclusive distributor of AG Cuffill, a syringe-like device for measuring airway cuff pressure and volume, across all U.S. healthcare markets. Medline will leverage its network of over 400 acute and surgery center sales representatives to expand the product's hospital and surgery center presence. The partnership aligns with Hospitech's goal of providing broader access to its airway cuff pressure management device, which is already in use at hundreds of hospitals and EMS teams in the U.S., Europe, Asia, and other markets.PR NewswireHospitech Respiration announces partnership with Medline Industries for distributing its AG Cuffill device in the USAHospitech Respiration has partnered with Medline Industries to make Medline the exclusive distributor of its AG Cuffill device in the United States, effective October 2nd. This agreement aims to expand Hospitech's market reach and improve patient safety by minimizing cross-contamination risks during airway cuff pressure management.PR NewswireHospitech Respiration's Respiratory Guard System Prevents Complications in Mechanically Ventilated PatientsIsraeli medical device company Hospitech Respiration reported that over 600 ventilated patients have been successfully treated with its AnapnoGuard respiratory guard system across the US, Israel, and China. The system, which has received FDA, CE, and CFDA regulatory approvals, provides automated airway cuff pressure management and subglottic secretion evacuation to reduce ventilator-associated complications including pneumonia and tracheal injury. The company noted that while COVID-19 is expected to drive a 400% increase in ventilator demand in 2020, the associated pulmonary complications are expected to negatively affect market growth, positioning AnapnoGuard as a solution to address these complications.PR NewswireNovel Airway Management System by Hospitech, Reduces Ventilation Complications in Lung TransplantationHospitech Respiration announced a new publication from Mayo Clinic physicians describing the successful use of its AnapnoGuard airway management system in postoperative lung transplant patients. The system continuously monitors endotracheal tube cuff leaks, adjusts pressure, and evacuates subglottic secretions, potentially reducing complications from excessive cuff pressure and aspiration. The company plans to generate further supporting data as the system expands in the USA and Europe.